Citations (23)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Tharmala Tharmalingam, Xiaobing Han, Ashley Wozniak & Laura Saward. (2022) Polyclonal hyper immunoglobulin: A proven treatment and prophylaxis platform for passive immunization to address existing and emerging diseases. Human Vaccines & Immunotherapeutics 18:2.
Read now
Read now
Sayeh Ezzikouri, Jalal Nourlil, Soumaya Benjelloun, Michinori Kohara & Kyoko Tsukiyama-Kohara. (2020) Coronavirus disease 2019—Historical context, virology, pathogenesis, immunotherapy, and vaccine development. Human Vaccines & Immunotherapeutics 16:12, pages 2992-3000.
Read now
Read now
Articles from other publishers (21)
Xuemei He, Cai He, Weiqi Hong, Jingyun Yang & Xiawei Wei. (2023) Research progress in spike mutations of SARS‐CoV‐2 variants and vaccine development. Medicinal Research Reviews 43:4, pages 932-971.
Crossref
Crossref
Amy E. Schmidt, Peter Vogel, Carrie A. Chastain, Thomas Barnes, Nathan J. Roth & Toby L. Simon. (2022)
Analysis of 52 240 source plasma donors of convalescent
COVID
‐19 plasma: Sex, ethnicity, and age association with initial antibody levels and rate of dissipation
. Journal of Clinical Apheresis 37:5, pages 449-459.
Crossref
Crossref
Rena A. Mizrahi, Wendy Y. Lin, Ashley Gras, Ariel R. Niedecken, Ellen K. Wagner, Sheila M. Keating, Nikita Ikon, Vishal A. Manickam, Michael A. Asensio, Jackson Leong, Angelica V. Medina-Cucurella, Emily Benzie, Kyle P. Carter, Yao Chiang, Robert C. Edgar, Renee Leong, Yoong Wearn Lim, Jan Fredrik Simons, Matthew J. Spindler, Kacy Stadtmiller, Nicholas Wayham, Dirk Büscher, Jose Vicente Terencio, Clara Di Germanio, Steven M. Chamow, Charles Olson, Paula A. Pino, Jun-Gyu Park, Amberlee Hicks, Chengjin Ye, Andreu Garcia-Vilanova, Luis Martinez-Sobrido, Jordi B. Torrelles, David S. Johnson & Adam S. Adler. (2022) GMP Manufacturing and IND-Enabling Studies of a Recombinant Hyperimmune Globulin Targeting SARS-CoV-2. Pathogens 11:7, pages 806.
Crossref
Crossref
Reed AC Siemieniuk, Jessica J Bartoszko, Juan Pablo Díaz Martinez, Elena Kum, Anila Qasim, Dena Zeraatkar, Ariel Izcovich, Sophia Mangala, Long Ge, Mi Ah Han, Thomas Agoritsas, Donald Arnold, Camila Ávila, Derek K Chu, Rachel Couban, Ellen Cusano, Andrea J Darzi, Tahira Devji, Farid Foroutan, Maryam Ghadimi, Assem Khamis, Francois Lamontagne, Mark Loeb, Anna Miroshnychenko, Sharhzad Motaghi, Srinivas Murthy, Reem A Mustafa, Gabriel Rada, Bram Rochwerg, Charlotte Switzer, Per O Vandvik, Robin WM Vernooij, Ying Wang, Liang Yao, Gordon H Guyatt & Romina Brignardello-Petersen. (2021) Antibody and cellular therapies for treatment of covid-19: a living systematic review and network meta-analysis. BMJ, pages n2231.
Crossref
Crossref
Sheila M. Keating, Rena A. Mizrahi, Matthew S. Adams, Michael A. Asensio, Emily Benzie, Kyle P. Carter, Yao Chiang, Robert C. Edgar, Bishal K. Gautam, Ashley Gras, Jackson Leong, Renee Leong, Yoong Wearn Lim, Vishal A. Manickam, Angelica V. Medina-Cucurella, Ariel R. Niedecken, Jasmeen Saini, Jan Fredrik Simons, Matthew J. Spindler, Kacy Stadtmiller, Brendan Tinsley, Ellen K. Wagner, Nicholas Wayham, LaRee Tracy, Carina Vingsbo Lundberg, Dirk Büscher, Jose Vicente Terencio, Lucy Roalfe, Emma Pearce, Hayley Richardson, David Goldblatt, Anushka T. Ramjag, Christine V. F. Carrington, Graham Simmons, Marcus O. Muench, Steven M. Chamow, Bryan Monroe, Charles Olson, Thomas H. Oguin, Heather Lynch, Robert Jeanfreau, Rachel A. Mosher, Matthew J. Walch, Christopher R. Bartley, Carl A. Ross, Everett H. Meyer, Adam S. Adler & David S. Johnson. (2021) Generation of recombinant hyperimmune globulins from diverse B-cell repertoires. Nature Biotechnology 39:8, pages 989-999.
Crossref
Crossref
Emilie Jacque, Claire Chottin, Daphné Laubreton, Michel Nogre, Cécile Ferret, Sandrine de Marcos, Linda Baptista, Carole Drajac, Philippe Mondon, Christophe De Romeuf, Marie-Anne Rameix-Welti, Jean-François Eléouët, Sami Chtourou, Sabine Riffault, Gérald Perret & Delphyne Descamps. (2021) Hyper-Enriched Anti-RSV Immunoglobulins Nasally Administered: A Promising Approach for Respiratory Syncytial Virus Prophylaxis. Frontiers in Immunology 12.
Crossref
Crossref
Saly Kanj & Basem Al-Omari. (2021) Convalescent Plasma Transfusion for the Treatment of COVID-19 in Adults: A Global Perspective. Viruses 13:5, pages 849.
Crossref
Crossref
Alexandra Serra, Núria Marzo, Berta Pons, Pau Maduell, Maite López & Salvador Grancha. (2021) Characterization of antibodies in human immunoglobulin products from different regions worldwide. International Journal of Infectious Diseases 104, pages 610-616.
Crossref
Crossref
Norton Pérez-Gutiérrez & Paula Andrea Amador-León. (2021) Dengue: actualidades y estándares en el manejo clínico. Revisión de tema. Acta Colombiana de Cuidado Intensivo 21:1, pages 66-76.
Crossref
Crossref
José María Díez, Carolina Romero, Júlia Vergara-Alert, Melissa Belló-Perez, Jordi Rodon, José Manuel Honrubia, Joaquim Segalés, Isabel Sola, Luis Enjuanes & Rodrigo Gajardo. (2020) Cross-neutralization activity against SARS-CoV-2 is present in currently available intravenous immunoglobulins. Immunotherapy 12:17, pages 1247-1255.
Crossref
Crossref
Zhi-Guo Zhou, Di-Xuan Jiang, Shu-Min Xie, Jing Zhang, Fang Zheng, Hong Peng, Xuan Chen, Ji-Yang Liu & Lei Zhang. (2020) Low-dose corticosteroid combined with immunoglobulin reverses deterioration in severe cases with COVID-19. Signal Transduction and Targeted Therapy 5:1.
Crossref
Crossref
Hoi-Kei Wong & Cheuk-Kwong Lee. (2020) Pivotal role of convalescent plasma in managing emerging infectious diseases. Vox Sanguinis 115:7, pages 545-547.
Crossref
Crossref
Denise J. Wooding & Horacio Bach. (2020) Treatment of COVID-19 with convalescent plasma: lessons from past coronavirus outbreaks. Clinical Microbiology and Infection 26:10, pages 1436-1446.
Crossref
Crossref
José-María Díez, Carolina Romero & Rodrigo Gajardo. (2020) Currently available intravenous immunoglobulin contains antibodies reacting against severe acute respiratory syndrome coronavirus 2 antigens. Immunotherapy 12:8, pages 571-576.
Crossref
Crossref
Chih-Hung Wang & Gwo-Bin Lee. (2020) Screening of multiple hemoprotein-specific aptamers and their applications for the binding, quantification, and extraction of hemoproteins in a microfluidic system. Biomicrofluidics 14:2.
Crossref
Crossref
William Alonso, Pete Vandeberg, John Lang, Jeffrey Yuziuk, Rebecca Silverstein, Kenya Stokes, Dennis McBride, Maria Cruz, Doug Burns, W. Keither Merritt, Todd Willis & Juan I. Jorquera. (2020) Immune globulin subcutaneous, human 20% solution (Xembify®), a new high concentration immunoglobulin product for subcutaneous administration. Biologicals 64, pages 34-40.
Crossref
Crossref
Angel Guerra Márquez. (2020) Viejos remedios para nuevos males. El caso del plasma de convalecientes. Revista Mexicana de Medicina Transfusional 13:1, pages 27-30.
Crossref
Crossref
Marco Antonio Yamazaki-Nakashimada, Francisco Eduardo Rivas-Larrauri & Luis Adrián Rosales-Hernández. (2020) Medicamentos versátiles: buscando balas mágicas. Revista Latinoamericana de Infectología Pediátrica 33:1, pages 32-43.
Crossref
Crossref
Allen J. Duplantier, Amy C. Shurtleff, Cheryl Miller, Chih-Yuan Chiang, Rekha G. Panchal & Melek Sunay. 2020. Drug Discovery Targeting Drug-Resistant Bacteria. Drug Discovery Targeting Drug-Resistant Bacteria
171
222
.
Davide Mangioni, Giacomo Grasselli, Chiara Abbruzzese, Antonio Muscatello, Andrea Gori & Alessandra Bandera. (2019) Adjuvant treatment of severe varicella pneumonia with intravenous varicella zoster virus-specific immunoglobulins. International Journal of Infectious Diseases 85, pages 70-73.
Crossref
Crossref
Thomas B. Casale, Michael N. Teng, Jamie P. Morano, Thomas Unnasch & Charles J. Lockwood. (2018) Zika virus: An emerging infectious disease with serious perinatal and neurologic complications. Journal of Allergy and Clinical Immunology 141:2, pages 482-490.
Crossref
Crossref